Federal Register / Vol. 61, No. 88 / Monday, May 6, 1996 / Notices 20275

The proposed consent decree may be

examined at the United States

Department of Justice, Environment and

Natural Resources Division, Consent

Decree Library, 1120 G Street, N.W., 4th

Floor, Washington, D.C. 20005, (202)

624–0892. A copy of the proposed

partial consent decree may be obtained

in person or by mail from the Consent

Decree Library, 1120 G Street, N.W., 4th

Floor, Washington, D.C. 20005. In

requesting a copy, please refer to the

referenced case and enclose a check in

the amount of $40.00 (25 cents per page

reproduction costs), payable to the

Consent Decree Library. Attachments to

the proposed partial consent decree can

be obtained for the additional amount of

$31.00.

Joel M. Gross,

Chief Environmental Enforcement Section.

[FR Doc. 96–11221 Filed 5–3–96; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated February 2, 1996, and

published in the Federal Register on

February 13, 1996, (61 FR 5571),

Orpharm Inc., 728 West 19th Street,

Houston, Texas 77008, made

application to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Methadone (9250) ....................... II.

Methadone-intermediate (9254) II.

Levo-alphacetylmethadol (9648) II.

No comments or objections have been

received. DEA has considered the

factors in 21 U.S.C. § 823(a) and

determined that the registration of

Orpharm Inc. to manufacture the listed

controlled substances is consistent with

the public interest at this time.

Therefore, pursuant to 21 U.S.C. § 823

and 28 C.F.R. §§ 0.100 and 0.104, the

Deputy Assistant Administrator, Office

of Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

Dated: April 29, 1996.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 96–11254 Filed 5–3–96; 8:45 am]

BILLING CODE 4410–09–M

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on February 20, 1996, Penick

Corporation, 158 Mount Olivet Avenue,

Newark, New Jersey 07114, made

application, which was received for

processing on April 10, 1996, to the

Drug Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Coca Leaves (9040) .................... II.

Opium, raw (9600) ....................... II.

Opium poppy (9650) .................... II.

Opium Straw Concentrate (9670) II.

The firm plans to import the listed

controlled substances for the

manufacture of bulk pharmaceutical

controlled substances.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, DC

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than (30 days from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1311.42 (b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import basic classes of

any controlled substances in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1311.42 (a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: April 30, 1996.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 96–11215 Filed 5–3–96; 8:45 am]

BILLING CODE 4410–09–M

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on March 27, 1996, Research

Biochemicals, Limited Partnership,

Attn: Richard Milius, 1–3 Strathmore

Road, Natick, Massachusetts 01760,

made application to the Drug

Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Methaqualone (2565) .................. I

Ibogaine (7260) ........................... I

Tetrahydrocannabinols (7370) ..... I

Bufotenine (7433) ........................ I

Dimethyltryptamine (7435) .......... I

Etorphine (except HCl) (9056) .... I

Methylphenidate (1724) ............... II

Pentobarbital (2270) .................... II

Diprenorphine (9058) ................... II

Etorphine Hydrochloride (9059) II

Diphenoxylate (9170) .................. II

Metazocine (9240) ....................... II

Methadone (9250) ....................... II

Fentanyl (9801) ........................... II

The firm plans to import small

quantities of the controlled substances

to manufacture laboratory reference

standards and neurochemicals.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of